Search - tctmd.com

Displaying 361 - 380 of 788

Sort: Relevancy | Date

Presentation TVT 2021

Tricuspid Regurgitation With Guideline Medical Therapy: When Is the Best Timing for Mechanical Intervention?

Presenter: Robert Smith

July 20, 2021

Presentation TVT 2021

Impact of Timing of Surgery on Outcomes of Mitral Valve Surgery After Edge-to-Edge Transcatheter Mitral Repair: Results From The CUTTING-EDGE Registry

Presenter: Gilbert Tang

July 20, 2021

Presentation TVT 2021

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Presenter: Mathew Williams

July 20, 2021

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Presenter: Hasan Jilaihawi

June 21, 2020

Presentation TVT 2020

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

Presenter: Gennaro Giustino

June 21, 2020

Presentation TVT 2020

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Presenter: Tsuyoshi Kaneko

June 21, 2020

Presentation TVT 2020

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Presenter: Susheel K. Kodali

June 21, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

Presentation TVT 2020

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Presenter: Tsuyoshi Kaneko

June 20, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Presenter: Guilherme F. Attizzani

June 20, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

Early Experience With a Purpose-designed Temporary Pacing Guidewire for Transcatheter Heart Valve Implantation

Presenter: Mark Hensey

June 15, 2019

Advertisement

Tricuspid Regurgitation With Guideline Medical Therapy: When Is the Best Timing for Mechanical Intervention?

Impact of Timing of Surgery on Outcomes of Mitral Valve Surgery After Edge-to-Edge Transcatheter Mitral Repair: Results From The CUTTING-EDGE Registry

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Device Explants After TAVR Rare but Risky

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Newer TAVR Devices Reassure in Failed Surgical Valves

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Early Experience With a Purpose-designed Temporary Pacing Guidewire for Transcatheter Heart Valve Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content